AI synthesis of eight filings for Emerson Electric Co.
Emerson's fiscal year ends September 30. This narrative covers the fiscal year ended September 30, 2025 and the third quarter of fiscal 2026, the quarter ended June 30, 2026.
Sources: Annual Report on Form 10-K for the fiscal year ended September 30, 2025 (accession 0000032604-25-000087); Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (accession 0000032604-26-000043); and Current Reports on Form 8-K dated August 4, 2026 (accession 0000032604-26-000042), May 5, 2026 (accession 0000032604-26-000034), February 13, 2026 (accession 0000032604-26-000022), February 6, 2026 (accession 0000032604-26-000017), November 20, 2025 (accession 0000032604-25-000094) and November 14, 2025 (accession 0000032604-25-000091).
Business
Emerson is a global automation company. It sells the instruments, valves, control systems and industrial software that process, hybrid and discrete manufacturers use to run their plants, measuring pressure, temperature, flow and composition; regulating the movement of liquids and gases; executing control logic; and optimizing production with modeling and simulation software. Its customers are chemical, power and renewables, energy, life sciences, metals and mining, food and beverage, pulp and paper, automotive, medical, packaging and semiconductor producers, plus the professional trades served by its tools business. Revenue is overwhelmingly product- and software-license based, sold largely through a direct sales force, supplemented by independent representatives and, to a lesser extent, distributors buying for resale. In fiscal 2025 the company sold $18.0 billion, split by destination into the Americas at 51 percent, Asia, Middle East & Africa at 30 percent (China, 10 percent) and Europe at 19 percent; international sales including U.S. exports were 59 percent of the total. Emerson had approximately 71,000 employees and roughly 120 manufacturing locations at September 30, 2025, about 35 in the United States and 85 outside it, primarily in Europe and Asia. It was incorporated in Missouri in 1890 and is headquartered in St. Louis.
How it is organized today. On November 20, 2025 Emerson announced that, with its portfolio transformation complete, it had revised its management organization and updated its reportable segments. Effective in fiscal 2026 the company reports five segments in three groupings, and prior-period amounts have been reclassified to match. The former Discrete Automation segment was dissolved and its pieces distributed across three of the surviving segments. (The FY2025 10-K still describes the prior six-segment, two-group structure; the descriptions below follow the current one, from the November 20, 2025 8-K and Note 15 of the Q3 FY2026 10-Q, with product and brand detail drawn from the 10-K.)
Software & Systems group
- Control Systems & Software, automation systems, intelligent software and industrial AI. Distributed control systems, safety instrumented systems, SCADA, application software, digital twins, asset performance management and cybersecurity, sold mainly to process and hybrid manufacturers. Brands include DeltaV and Ovation control systems and AspenTech's asset optimization software, which lets industrial manufacturers design, operate and maintain their operations for maximum performance. The segment now also includes programmable automation controllers moved over from the former Discrete Automation segment.
- Test & Measurement, the former National Instruments business, now carrying the NI brand: software-connected automated test and measurement systems, modular instrumentation, data acquisition and control solutions and general-purpose development software, used to bring products to market faster and at lower cost.
Intelligent Devices group
- Sensors (formerly described as Measurement & Analytical), intelligent instrumentation measuring pressure, temperature, level, flow, acoustics, corrosion, pH, conductivity, water quality, toxic gases and flame, feeding data to control systems and automation software. Brands include Rosemount, Micro Motion and Flexim.
- Final Control, control, isolation, shutoff, pressure relief and pressure safety valves, digital valve controllers, actuators and regulators. Brands include Fisher, ASCO, Bettis, Anderson Greenwood, Crosby, Keystone, KTM and Vanessa. The segment now also includes the fluid & motion control business from the former Discrete Automation segment, solenoid and pneumatic valves, valve position indicators, cylinders, air preparation equipment and electric linear motion.
Safety & Productivity
- Tools and connected equipment for mechanical, electrical and plumbing professionals: pipe wrenches and cutters, threading and roll-grooving equipment, battery hydraulic press and crimping tools, drain cleaners, sewer inspection cameras and locating equipment, conduit benders, cable pulling equipment, water jetters and vacuums. Brands include RIDGID, Greenlee, Klauke and ProTeam. Recently expanded to include the electrical equipment and materials joining businesses from the former Discrete Automation segment.
How the portfolio got here. Emerson describes portfolio management as integral to its growth and value creation strategy, and the past three years reshaped the company into a narrower, higher-growth, higher-margin automation franchise:
- AspenTech buy-in, on March 12, 2025 Emerson completed the purchase of the AspenTech common stock it did not already own for approximately $7.2 billion, making AspenTech a wholly owned subsidiary reporting into Control Systems & Software. Emerson incurred fees of $76 million ($65 million after tax) and paid $76 million to settle AspenTech share-based awards; AspenTech separately incurred $127 million ($113 million after tax) of deal-related fees. AspenTech's results, formerly a separate segment, are now consolidated into Control Systems & Software for all periods presented.
- National Instruments, acquired October 11, 2023 at an equity value of $8.2 billion; NI had revenues of approximately $1.7 billion and pretax earnings of approximately $170 million for the twelve months ended September 30, 2023. It is now Test & Measurement.
- Open Grid Systems Limited, acquired by AspenTech on November 15, 2024 for a total purchase price of $46 million net of cash; a network model management technology provider.
- Flexim and Afag, acquired in 2023 for $715 million net of cash.
- Climate Technologies / Copeland, on May 31, 2023 Emerson sold a majority stake in Climate Technologies to private equity funds managed by Blackstone in a $14.0 billion transaction, recognizing a pretax gain of approximately $10.6 billion (approximately $8.4 billion after tax) and retaining a 40 percent non-controlling interest in the standalone business, Copeland. In August 2024 it sold that 40 percent interest to Blackstone funds for $1.5 billion and the related note receivable to Copeland for $1.9 billion.
- InSinkErator, divested to Whirlpool Corporation on October 31, 2022 for $3.0 billion, producing a pretax gain of approximately $2.8 billion (approximately $2.1 billion after tax).
- Metran, Emerson's Russia-based manufacturing subsidiary, divested March 31, 2023; a pretax loss of $47 million was recognized on the exit of Russian operations, which had historically represented approximately 2.0 percent of consolidated annual sales.
Other business characteristics. Spending on R&D, engineering expense and customer-funded engineering and development was 8.1 percent of sales in both fiscal 2025 and fiscal 2024, up from 6.9 percent in 2023. Estimated consolidated order backlog was $8.6 billion at September 30, 2025 against $8.4 billion a year earlier (Intelligent Devices $4,499 million; Software and Control $4,130 million, on the then-current segment structure), with approximately 75 percent expected to convert to revenue within twelve months. Principal raw materials are steel, cast iron, electronics, rare earth metals, aluminum and brass, with plastics and petroleum-based chemicals to a lesser extent; Emerson seeks multiple sources for each to avoid dependence on any one supplier. Management does not regard any segment as dependent on a single patent, trademark or license. Emerson maintains a cybersecurity risk management program overseen by the Audit Committee and the Board, run by a Chief Information Security Officer who briefs the Audit Committee quarterly; the company states that to date no cybersecurity threat or incident has materially affected its business, strategy, results or financial condition.
(Business section from the FY2025 10-K, accession 0000032604-25-000087, with the current segment structure from the November 20, 2025 8-K, accession 0000032604-25-000094, and Note 15 of the Q3 FY2026 10-Q, accession 0000032604-26-000043.)
Risk factors
Condensed from Item 1A of the FY2025 10-K (accession 0000032604-25-000087). Emerson groups its risks into business and operational, industry and general economic, and legal and regulatory.
Business and operational
- Competition. Markets are highly competitive and potentially volatile; Emerson competes on product performance, quality, service and price. Some competitors have substantially greater sales, assets and financial resources. Competitive pressure could hit prices, demand, margins or market share. Certain businesses also depend on independent sales representatives and distributors, and the sale, financial instability or defection of one of those channel partners could weaken Emerson's position.
- Product development and technological change. Businesses are affected by varying degrees of technological change, artificial intelligence and machine learning among them, producing unpredictable product transitions, shortened life cycles and a premium on being first to market. Emerson may fail to recoup R&D investment. It also flags the risk of not positioning for adoption of battery storage, industrial hydrogen, mobility and power generation, enhanced grid demand management, carbon capture and sequestration, or advanced nuclear power.
- Intellectual property. Patents, trademarks, copyrights and trade secrets may be challenged, infringed, invalidated or circumvented, or misappropriated through unauthorized system access, employee theft or industrial espionage.
- Acquisitions and divestitures. Deals require favorable environments and domestic and foreign regulatory approvals. As a result of the AspenTech, NI and Climate Technologies transactions Emerson explicitly notes it now has a narrower business focused on higher-growth markets, and may encounter more volatility and be more vulnerable to changing market conditions. Integration, separation and the timing and degree of anticipated benefits are all uncertain.
- Raw materials. Shortages or price increases in steel, cast iron, electronics, rare earth metals, aluminum, brass, plastics and petroleum-based chemicals could raise operating costs and hurt competitive position; hedging may not fully mitigate.
- Global production footprint. A majority of manufacturing facilities are outside the United States and emerging-market sales represent over one-third of total sales. Facilities are exposed to weather and natural disaster (including climate change effects), labor strife, war (Russia-Ukraine and other global conflicts), political unrest, terrorism, epidemics, nationalization and host-country legal and political upheaval.
- Capital markets access. Investing, acquiring and refinancing maturing debt all require access to capital markets and bank credit lines for short-term borrowings; volatility raises the cost of commercial paper and other debt or could close off access entirely. Customers, suppliers or financial institutions losing that access would also hurt Emerson.
- Key personnel. Success depends in part on the skills, experience and industry knowledge of management and key employees.
- Security and data privacy. IT networks are exposed to failures, outages, terrorism, natural disaster, employee error or malfeasance, server and cloud-provider breaches, and cyberattacks ranging to advanced persistent threats. Emerson expects cyberattack risk to increase as AI capabilities improve and are used both to find vulnerabilities and to build attacks, with additional exposure from its own and its vendors' AI use. Breaches could mean theft of trade secrets, disclosure of confidential data, litigation, penalties under privacy laws and reputational damage; compliance with privacy and data-localization regimes increases operational complexity.
- Product failure. Products and services incorporate complex, leading-edge hardware and software integrated into process, hybrid and discrete manufacturing environments, so the impact of a catastrophic product failure could be significant. Cybersecurity incidents aimed at embedded software could generate third-party damage claims, a risk enhanced by the increasingly connected nature of the products.
- Artificial intelligence. AI use raises accuracy, IP infringement, data privacy and cybersecurity risks; competitors may adopt AI faster or better; and the regulatory landscape is rapidly evolving with potentially prohibitive requirements.
Industry and general economic
- Trade policy, tariffs and currency. Emerson sells, manufactures, engineers and purchases globally across mature and emerging markets. Changes in trade terms, restrictions, tariffs, taxes, protection measures and retaliatory countermeasures could hurt results. The 10-K states directly that recent changes in U.S. trade policy, the application or increase of tariffs and subsequent retaliatory measures, have created a dynamic environment and that there is no assurance Emerson can mitigate the full impact on its costs, demand, supply chain or the global economy. Currency swings have affected operating results and hedging may not offset them.
- Recession and end-market downturns. Operations have historically been exposed to significant volatility from general economic conditions and end-market downturns, which could depress sales, trigger goodwill or long-lived asset impairment charges, and force more extensive and costlier restructuring, workforce reductions, facility consolidations, centralization, whose benefits may be delayed or never realized.
Legal and regulatory
- Tax. Emerson is taxed in the U.S. and numerous non-U.S. jurisdictions. Its effective rate, cash flows and results can move with the geographic mix of earnings, local law changes and the multiple overlapping regimes implementing the OECD global minimum tax. Returns are regularly audited and disputes could adjust tax liabilities.
- Improper conduct. Exposure to the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act and similar laws, with operations in many parts of the world that have experienced government corruption; internal controls may not always prevent improper conduct by employees, agents or business partners.
- Litigation and environmental. Emerson is party to proceedings involving intellectual property, commercial transactions, government contracts, the integration of emerging technologies including AI, M&A, employment, benefit plans, antitrust, anti-corruption, accounting, import and export, health and safety, product liability including asbestos, and environmental matters. It could incur substantial cleanup or damage costs under environmental laws, and notes a continuing lack of consistent climate-change legislation and standards. Sustainability goals depend on technologies not yet commercially available and on the efforts of suppliers and others; failing or being perceived to fail to meet them could bring reputational damage, enforcement actions and private litigation.
Related contingency disclosure. Emerson engages an outside expert for an actuarial estimate of expected costs to resolve all pending and future asbestos claims including defense costs, plus related insurance receivables; the asbestos reserve is recorded undiscounted and is based on projected claims through 2065. At September 30, 2025 there were no known contingent liabilities management believed would be material to the financial statements, nor any material commitments outside the normal course of business. At June 30, 2026 the balance sheet carried $119 million of asbestos litigation liability in Other liabilities and $50 million of asbestos-related insurance receivables in Other assets.
MD&A, fiscal year ended September 30, 2025
From Item 7 of the FY2025 10-K (accession 0000032604-25-000087). Dollars in millions except per-share amounts unless noted.
Top line. Net sales were $18.0 billion, up $0.5 billion or 3 percent. Underlying sales, excluding currency translation, acquisitions and divestitures, were also up 3 percent, on 2.5 percent higher price and 0.5 percent higher volume. Underlying sales rose 5 percent in the U.S. and 1 percent internationally. International destination sales including U.S. exports rose 1 percent to $10.6 billion, with U.S. exports of $1.4 billion up 5 percent; underlying, Asia, Middle East & Africa was up 3 percent (China down 4 percent) and Canada up 7 percent, while Europe fell 2 percent and Latin America was flat. Origin sales by international subsidiaries totaled $9.4 billion, up 1 percent.
Margins and costs. Cost of sales fell $110 to $8,497. Gross profit was $9,519 against $8,885, and gross margin rose 2.0 percentage points to 52.8 percent, the prior year had carried $231 of acquisition-related inventory step-up amortization worth roughly 1.3 points of margin, and favorable price less net material inflation added to the gain. SG&A of $5,103 was down $39, falling 1.1 points to 28.3 percent of sales on cost-reduction savings concentrated at Test & Measurement and AspenTech. Other deductions, net of $1,245 were down $189: intangibles amortization fell $193 (the prior year included $136 of backlog amortization tied to Test & Measurement) and restructuring fell $92, partly offset by $118 higher acquisition/divestiture fees and related costs. Interest expense, net was $237 against $175 in 2024 and $34 in 2023, the increase reflecting higher debt to support the AspenTech transaction.
Earnings. Pretax earnings from continuing operations of $2,934 rose $914, or 45 percent, with Intelligent Devices up $146 and Software and Control up $545. Income taxes were $696 at a 24 percent effective rate, against 21 percent in 2024 and 22 percent in 2023; discrete tax items of $36 ($0.06 per share) and non-deductible AspenTech fees added roughly 2 points. Net earnings from continuing operations attributable to common stockholders were $2,285, up 41 percent from $1,618, and diluted EPS from continuing operations was $4.03, up 43 percent from $2.82. The prior year had absorbed NI purchase accounting, higher associated restructuring, and a pretax loss of $279 ($217 after tax, $0.38 per share) on the agreement to sell the Copeland note receivable for $1.9 billion. Adjusted diluted EPS from continuing operations was $6.00 against $5.49. Discontinued operations contributed $8 ($0.01 per share) versus $350 ($0.61) in 2024, so net earnings attributable to common stockholders were $2,293 ($4.04 per share) against $1,968 ($3.43).
Segments, on the then-current structure. Intelligent Devices sales were $12.4 billion, up $239 or 2 percent, with underlying up 2 percent on price; Final Control rose $176 (4 percent) on strength in power end markets, Measurement & Analytical rose $82 (2 percent) on mixed geographies and difficult comparisons, Discrete Automation rose $15 (1 percent), and Safety & Productivity fell $34 (2 percent) on softness in all geographies. Intelligent Devices earnings were $2,953, up $146 or 5 percent, with margin up 0.7 points to 23.8 percent and adjusted EBITA margin up 0.5 points to 25.9 percent. Software and Control sales were $5.7 billion, up $292 or 5 percent, underlying up 5 percent on 2.5 percent higher volume and 2.5 percent higher price; Control Systems & Software rose $270 (7 percent) on strong AspenTech growth, including a favorable contract-renewal timing effect, and demand in process and power, while Test & Measurement rose $22 (2 percent). Software and Control earnings were $827, up $545 or 193 percent, with margin up 9.3 points to 14.5 percent and adjusted EBITA margin up 4.0 points to 31.0 percent.
Cash and capital structure. Operating cash flow from continuing operations was $3.7 billion, up $359 or 11 percent on higher earnings and favorable working capital changes; free cash flow from continuing operations was $3,245, up 12 percent. Including discontinued operations, total operating cash flow was $3,098, held back by roughly $0.6 billion of income taxes paid on the Copeland equity sale, the same payment that pushed operating working capital to 11.3 percent of sales from 8.0 percent. Net cash paid for acquisitions was $37, against $8,342 in 2024. Total debt rose to $13,116 from $7,687, with commercial paper borrowings at approximately $4.2 billion at year end; in March 2025 Emerson issued €500 of 3.0% notes due 2031, $500 of 5.0% notes due 2035 and €500 of 3.5% notes due 2037. Management acknowledged leverage and debt ratios elevated versus historical levels while expecting to retain investment-grade ratings and to improve the ratios through disciplined capital allocation. Dividends were $1,192 ($2.11 per share) and share repurchases $1,167 (9.3 million shares at an average $125.66). Total assets were $42 billion and stockholders' equity $20 billion. A $3 billion 364-day backup facility entered February 11, 2025 sat alongside a $3.5 billion revolver from February 2023, with no borrowings ever drawn under either.
Retirement plans. At September 30, 2025 U.S. pension plans were overfunded by $856 in total, roughly 29 percent in excess of the projected benefit obligation, while non-U.S. plans were underfunded by $65. Effective January 1, 2025 Emerson implemented a new profit sharing retirement program for U.S. non-union employees, funded by surplus pension assets, and froze future service accruals in the principal U.S. defined benefit plan after December 31, 2024.
Current quarter, third quarter of fiscal 2026 (quarter ended June 30, 2026)
From the Q3 FY2026 10-Q (accession 0000032604-26-000043) and the third-quarter results press release furnished as Exhibit 99.1 to the 8-K dated August 4, 2026 (accession 0000032604-26-000042). Dollars in millions except per-share amounts unless noted.
The quarter. Net sales were $4,873, up 7 percent from $4,553. Underlying sales were up 6 percent on 3 percent higher volume and 3 percent higher price, with currency translation adding 1 point. Underlying orders, a trailing three-month average excluding currency, significant M&A and AspenTech, were up 7 percent. Underlying sales rose 10 percent in the U.S. and 4 percent internationally: the Americas up 8 percent, Asia, Middle East & Africa up 8 percent (China down 3 percent) and Europe down 1 percent. Chief Executive Lal Karsanbhai described demand as robust, led by Software & Systems and broad-based growth in North America and Asia, while noting that the conflict in the Middle East remains fluid.
Tariff refunds. In February 2026 the U.S. Supreme Court ruled that the International Emergency Economic Powers Act does not authorize the imposition of tariffs, and on April 20, 2026 U.S. Customs and Border Protection opened an administrative portal for refund claims. During the quarter Emerson filed claims and received tariff refunds of $82 ($0.11 per share), recorded in cost of sales. The timing and amount of any further refunds remain uncertain and no benefit was recognized at June 30, 2026 for additional potential refunds of previously paid IEEPA tariffs. This single item is the principal driver of the quarter's gross-margin expansion and is excluded from adjusted EPS.
Margins and earnings. Cost of sales was $2,218, up $58, and gross margin of 54.5 percent rose 1.9 points, primarily on the tariff refunds. SG&A of $1,343 rose $77 but fell 0.2 points to 27.6 percent of sales on operating leverage and cost-reduction savings. Other deductions, net were $311, up $13, as restructuring costs rose (to $87 from $37) against lower intangibles amortization ($204 from $219). Interest expense, net was $85, down from $95. Pretax earnings from continuing operations were $916, up $182 or 25 percent, at an 18.8 percent margin, 270 basis points better than the prior year. Income taxes were $198 at a 22 percent effective rate versus $154 and 21 percent, with the One Big Beautiful Bill Act adding about 1 point through a lower foreign-derived intangible income deduction following the change to domestic research and development treatment in fiscal 2026; Emerson expects the OBBBA to slightly benefit the rate from fiscal 2027. Earnings from continuing operations attributable to common stockholders were $718, up 24 percent, and diluted EPS from continuing operations was $1.28 against $1.03; including the year-ago quarter's discontinued operations, total diluted EPS was $1.28 against $1.04. Adjusted diluted EPS was $1.71 against $1.52, up 13 percent. Adjusted total segment EBITA was $1,387 at a 28.5 percent margin, up 140 basis points from $1,232 and 27.1 percent.
Segments (current five-segment structure).
- Software & Systems, sales $1,644, up $164 or 11 percent, underlying up 11 percent on 7 percent higher volume and 4 percent higher price. Control Systems & Software sales were $1,199, up 7 percent on strong demand in power; Test & Measurement was $445, up 23 percent on semiconductor and aerospace & defense strength. Underlying sales rose 13 percent in the Americas and 16 percent in Asia, Middle East & Africa (China up 14 percent) while Europe fell 1 percent. Earnings were $296, up 21 percent, with margin up 1.4 points to 18.0 percent on leverage, lower intangibles amortization and cost-reduction savings; adjusted EBITA margin was 31.8 percent, down 0.3 points. Test & Measurement swung to a $11 segment profit from a $26 loss.
- Intelligent Devices, sales $2,677, up $142 or 6 percent, underlying up 5 percent on 3 percent higher price and 2 percent higher volume. Sensors rose $78 (8 percent) on Americas strength in power and LNG; Final Control rose $64 (4 percent) on Asia, Middle East & Africa and Americas growth, again led by power. Earnings rose $55, or 9 percent, with margin up 0.8 points to 24.3 percent on leverage and favorable price less net material inflation, partly offset by unfavorable mix from increased greenfield project activity and higher restructuring. Adjusted EBITA margin was 27.9 percent, up 2.4 points.
- Safety & Productivity, sales $552, up $14 or 3 percent, underlying up 2 percent on 4 percent higher price against 2 percent lower volume. The Americas rose 4 percent and Asia, Middle East & Africa 1 percent while Europe fell 6 percent. Earnings fell $10, or 10 percent, with margin down 2.3 points to 16.9 percent on higher restructuring and deleverage on lower volume; adjusted EBITA margin rose 0.8 points to 21.2 percent.
Nine months. Net sales were $13,781, up 5 percent, with underlying up 3 percent on 3 percent higher price while volume took an approximately 1.5 percent hit from the timing of software renewals and the conflict in the Middle East; currency added 2 points. Gross margin of 53.6 percent rose 0.4 points on favorable price less net material inflation and the $82 of tariff refunds, partly offset by software-renewal timing. SG&A of $3,902 was 28.3 percent of sales, down 0.4 points. Other deductions, net fell $200 to $744, driven by a $175 decline in acquisition/divestiture fees tied to the prior-year AspenTech transaction and the absence of $65 of AspenTech backlog amortization. Interest expense, net rose $113 to $258 on higher short-term borrowings and long-term debt used to fund AspenTech in March 2025. Pretax earnings of $2,484 were up $346. The effective tax rate fell to 22 percent from 25 percent, favorable tax items worth about 2 points, and the absence of $49 ($0.09 per share) of prior-year AspenTech discrete taxes and non-deductible fees worth about 3 points, against the roughly 1-point OBBBA drag. Earnings from continuing operations attributable to common stockholders were $1,941, up 18 percent, with diluted EPS of $3.45 against $2.91 and adjusted diluted EPS of $4.71 against $4.38. By segment for the nine months: Software & Systems sales $4,600 (up 7 percent) and earnings $762 (up $109, or 17 percent, margin up 1.4 points, adjusted EBITA margin 30.8 percent, down 0.9 points including roughly 2 points of software-renewal timing drag); Intelligent Devices sales $7,580 (up 4 percent) and earnings up $71 with margin flat and adjusted EBITA margin up 0.9 points; Safety & Productivity sales $1,601 (up 3 percent) with earnings down $7.
Cash and balance sheet. Operating cash flow was $1,425 in the quarter, up 34 percent, and free cash flow $1,323, up 36 percent. For the nine months, operating cash flow from continuing operations was $2,902, up $238, and free cash flow $2,618 after $284 of capital expenditures, up $217. Total cash provided by operating activities was $2,902 against $2,088, the improvement reflecting $585 of income taxes paid in the second quarter of fiscal 2025 on the Copeland equity sale that did not recur. Cash used in investing was $322; cash used in financing was $1,920, comprising $898 of share repurchases and $935 of dividends. In the first quarter Emerson repaid €500 of 1.25% euro notes that matured in October 2025. At June 30, 2026 total assets were $42,208, cash $2,180, inventories $2,513, goodwill $18,122, other intangible assets $8,686, short-term borrowings and current maturities $5,587, long-term debt $7,526 and common stockholders' equity $20,379. Operating working capital of $2,290 was up $251 from September 30, 2025 on higher inventory; the current ratio was 0.9, total debt-to-total capital 39.2 percent, net debt-to-net capital 34.9 percent, and the interest coverage ratio 8.2X for the trailing twelve months against 9.6X a year earlier, the decline reflecting higher interest expense. Remaining performance obligations, Emerson's backlog measure in the quarterly report, were approximately $9.6 billion, with roughly 75 percent expected to convert within twelve months. Emerson expects fiscal 2026 restructuring expense and related costs of approximately $185.
Capital returns. Emerson repurchased 2,543 thousand shares during the quarter at an average $139.21. In November 2025 the Board authorized the purchase of up to 50 million shares, on top of the March 2020 authorization for 60 million; approximately 63.2 million shares remained available at June 30, 2026. Also in November 2025 the Board raised the quarterly dividend to an annualized rate of $2.22 per share. In January 2026 the company's 2025 Employee Stock Purchase Plan commenced, permitting eligible employees to buy discounted stock through payroll deductions, with a maximum of 10 million shares issuable over the plan's term.
Fiscal 2026 outlook, raised. Alongside the third-quarter results Emerson raised its full-year guidance. Consolidated net sales are expected up approximately 5 percent, with underlying sales up approximately 3.5 percent excluding a 1.5 percent favorable currency impact. Diluted EPS is expected at approximately $4.89 and adjusted EPS at approximately $6.55, the bridge comprising roughly $1.39 of intangibles amortization, $0.24 of restructuring and related costs, $0.09 of acquisition/divestiture fees, $0.05 of discrete taxes and $(0.11) of IEEPA tariff refunds. Operating cash flow is expected at approximately $4.1 billion and free cash flow at approximately $3.6 billion after roughly $0.45 billion of capital spending. The outlook assumes returning approximately $2.2 billion to shareholders, about $1.0 billion of repurchases and about $1.2 billion of dividends. For the fourth quarter specifically, guidance calls for net sales growth of approximately 5 percent, underlying growth of approximately 5 percent, EPS of approximately $1.45 and adjusted EPS of approximately $1.85. For comparison, the outlook issued with the FY2025 10-K in November 2025 called for sales up approximately 5.5 percent, underlying up approximately 4 percent, EPS of $4.73 to $4.93, adjusted EPS of $6.35 to $6.55, operating cash flow of $4.0 to $4.1 billion and free cash flow of $3.5 to $3.6 billion.
Other developments during fiscal 2026. On February 10, 2026 Emerson entered a $2 billion, 364-day revolving backup credit facility with JPMorgan Chase Bank, N.A. as agent, expiring February 9, 2027, replacing the $3 billion 364-day facility from February 11, 2025 that expired by its terms; it sits alongside the existing $3.5 billion five-year revolver from February 2023. Neither facility has ever been drawn, and there are no outstanding loans or letters of credit under the new one (8-K dated February 13, 2026, accession 0000032604-26-000022). At the annual meeting held February 3, 2026, shareholders elected three directors, approved executive compensation on an advisory basis and ratified KPMG LLP as auditor for fiscal 2026; a proposal to amend the Restated Articles of Incorporation to declassify the Board received 415,208,804 votes for against 5,746,906 opposed but failed because it required 85 percent of outstanding shares (8-K dated February 6, 2026, accession 0000032604-26-000017). On November 13, 2025 the Compensation Committee granted Special Performance-based Awards to President and CEO Lal Karsanbhai and Executive Vice President and Chief Operating Officer Ram Krishnan, 350,000 stock options each, in five tranches of 70,000 at exercise prices of $128.46 (the grant-date close), $160.575, $192.69, $224.805 and $256.92 per share, representing premiums of 25, 50, 75 and 100 percent; each tranche vests pro rata over five years and must be exercised within ten years (8-K dated November 14, 2025, accession 0000032604-25-000091). There has been no significant change in Emerson's market risk exposure during the three and nine months ended June 30, 2026, and management concluded disclosure controls and procedures were effective with no material change in internal control over financial reporting during the quarter.
Subsequent events
The Q3 FY2026 10-Q (accession 0000032604-26-000043) contains no subsequent-events note; its fifteen notes run from basis of presentation through business segments without one, and Part II of that report raises no post-period matter. No acquisition, divestiture, financing, borrowing or litigation outcome is disclosed as occurring after June 30, 2026 in that filing.
The material post-period items Emerson has disclosed are:
- Quarterly dividend declared, August 4, 2026. Emerson declared a quarterly cash dividend of $0.555 per share of common stock, payable September 10, 2026 to stockholders of record on August 14, 2026 (8-K dated August 4, 2026, accession 0000032604-26-000042, Exhibit 99.1). This is consistent with the annualized $2.22 per share rate the Board set in November 2025.
- Fiscal 2026 outlook raised, August 4, 2026. Full-year guidance was increased to approximately 5 percent net sales growth, approximately $4.89 of EPS and approximately $6.55 of adjusted EPS, with operating cash flow of approximately $4.1 billion and free cash flow of approximately $3.6 billion (same 8-K and exhibit). The detail is set out in the current-quarter section above.
- Board addition effective August 3, 2026. Jennifer G. Newstead joined Emerson's Board of Directors effective August 3, 2026, having been elected by the Board on May 5, 2026, and was appointed to the Compensation Committee and the Corporate Governance and Nominating Committee as of that date. Ms. Newstead is Senior Vice President and General Counsel of Apple and was previously Chief Legal Officer at Meta; the Board determined she is independent. She receives an award of restricted stock units representing a $95,000 pro rata portion of the $190,000 RSU component of the annual non-management director retainer (8-K dated May 5, 2026, accession 0000032604-26-000034, Item 5.02).
Emerson's fourth quarter of fiscal 2026 ends September 30, 2026; results for that quarter and the full fiscal year had not been reported as of the filings covered here.
AI synthesis of events in 15 filings
Filings that contain financial statements
Emerson is a domestic filer, so its reviewed interim statements live in the Forms 10-Q. Each quarterly earnings release furnished as Exhibit 99.1 to a Form 8-K nonetheless carries a full set of unaudited consolidated tables, and those are the primary public source for the quarter's figures on the day they are released:
- Form 8-K filed August 4, 2026, accession 0000032604-26-000042 (Exhibit 99.1, third quarter fiscal 2026). Consolidated operating results for the quarter and nine months ended June 30, 2026; consolidated balance sheet at June 30, 2026 with September 30, 2025 comparative; consolidated statement of cash flows for the nine months ended June 30, 2026 only. The three-month operating and free cash flow figures ($1,425 million and $1,323 million) appear in the release's highlights and reconciliation tables, not in the cash flow statement itself.
- Form 8-K filed May 5, 2026, accession 0000032604-26-000034 (Exhibit 99.1, second quarter fiscal 2026). Quarter and six months ended March 31, 2026; balance sheet at March 31, 2026; cash flows for the six months ended March 31, 2026.
- Form 8-K filed February 3, 2026, accession 0000032604-26-000006 (Exhibit 99.1, first quarter fiscal 2026). Quarter ended December 31, 2025; balance sheet at December 31, 2025; cash flows for the three months ended December 31, 2025.
- Form 8-K filed November 5, 2025, accession 0000032604-25-000079 (Exhibit 99.1, fourth quarter and fiscal year ended September 30, 2025). Quarter and full-year operating results, balance sheet at September 30, 2025 with the prior-year comparative, and full-year cash flows.
- Form 8-K filed November 20, 2025, accession 0000032604-25-000094 (Exhibit 99.1). Supplemental unaudited historical segment sales, cost of sales, gross profit and earnings for fiscal 2021 through fiscal 2025, recast onto the five-segment structure adopted for fiscal 2026. Explicitly not a restatement of previously issued financial statements.
The Form 10-Q for the quarter ended June 30, 2026 is accession 0000032604-26-000043, filed August 4, 2026; the Form 10-K for fiscal 2025 is accession 0000032604-25-000087, filed November 10, 2025.
Results and guidance
August 4, 2026, Third quarter fiscal 2026 results; full-year outlook raised. Net sales of $4,873 million were up 7% (underlying sales up 6%), pretax earnings were $916 million at a 18.8% margin (up 270 basis points), GAAP EPS was $1.28 and adjusted EPS $1.71. Operating cash flow was $1,425 million and free cash flow $1,323 million. Management raised full-year fiscal 2026 guidance to approximately $4.89 GAAP EPS and approximately $6.55 adjusted EPS, with net sales growth of approximately 5% and free cash flow of approximately $3.6 billion, the top of the range given in May. Underlying orders were up 7%, led by Software & Systems. CEO Lal Karsanbhai noted that "the conflict in the Middle East remains fluid." (Accession 0000032604-26-000042.)
May 5, 2026, Second quarter fiscal 2026 results; outlook updated. Net sales of $4,562 million were up 3% but underlying sales grew only 0.5%, which management attributed to the impact of the conflict in the Middle East. Adjusted segment EBITA margin slipped 40 basis points to 27.6% while pretax margin rose 320 basis points to 17.4%; adjusted EPS was $1.54 against GAAP EPS of $1.10. Full-year guidance was trimmed to net sales growth of approximately 4.5% (from approximately 5.5%) and underlying growth of approximately 3% (from approximately 4%), while the adjusted EPS range was lifted at the low end to $6.45–$6.55 from $6.40–$6.55. (Accession 0000032604-26-000034.)
February 3, 2026, First quarter fiscal 2026 results. Net sales of $4,346 million were up 4%, underlying sales up 2%, and underlying orders up 9%, described as a fourth consecutive quarter of strong orders growth. Pretax margin fell 80 basis points to 17.8%; adjusted EPS was $1.46. Full-year guidance for net sales growth was held at approximately 5.5% with underlying growth of approximately 4%, and the adjusted EPS range was narrowed upward at the low end to $6.40–$6.55 from $6.35–$6.55. (Accession 0000032604-26-000006.)
November 5, 2025, Fourth quarter and fiscal 2025 results; initial fiscal 2026 outlook. Fiscal 2025 net sales were $18,016 million, up 3%, with pretax margin of 16.3% (up 480 basis points), GAAP EPS of $4.03 from continuing operations and adjusted EPS of $6.00. Free cash flow was $3,245 million, up 12%. Management said it had completed the Test & Measurement integration and delivered on its commitment to $200 million of run-rate cost synergies. Initial fiscal 2026 guidance was $6.35–$6.55 adjusted EPS on approximately 5.5% sales growth. (Accession 0000032604-25-000079.)
Capital returns and capital structure
November 5, 2025, Dividend raised 5% and a new 50 million share repurchase authorization. The quarterly dividend was increased 5% to $0.555 per share, payable December 10, 2025. The Board separately authorized the repurchase of up to 50 million shares of common stock over the next several years, in addition to the March 2020 authorization for 60 million shares, of which approximately 20 million shares remained available. (Accession 0000032604-25-000079.)
The $0.555 quarterly rate was declared again alongside each subsequent quarter's results, payable March 10, 2026 (accession 0000032604-26-000006), June 10, 2026 (accession 0000032604-26-000034) and September 10, 2026 (accession 0000032604-26-000042). Across fiscal 2026 the company has framed its capital allocation as a pivot toward returning cash to shareholders: approximately $2.2 billion for the year, split roughly $1.0 billion of buybacks and $1.2 billion of dividends. Through the nine months ended June 30, 2026 it had paid $935 million of dividends and repurchased $898 million of stock.
February 10, 2026, New $2 billion 364-day credit facility. Emerson entered into a $2 billion 364-day credit agreement with JPMorgan Chase Bank as agent, expiring February 9, 2027. It replaces the $3 billion 364-day facility entered into on February 11, 2025, which expired by its terms, a $1 billion reduction in committed backstop capacity. The facility is unsecured and supports general corporate purposes including backing commercial paper; the company states there are no outstanding loans or letters of credit under it, that it has never borrowed under this or prior similar facilities, and that it has no current intention to do so. (Accession 0000032604-26-000022.)
March 4, 2025, $1.5 billion of notes issued to help fund the AspenTech buy-in. Emerson closed public offerings of €500 million of 3.000% Notes due 2031, €500 million of 3.500% Notes due 2037 and $500 million of 5.000% Notes due 2035, for net proceeds of approximately $1,536.7 million before expenses. Proceeds were earmarked for general corporate purposes, repayment of commercial paper and part of the AspenTech purchase price. The pricing agreements had been signed on February 25, 2025. (Accessions 0001140361-25-006938 and 0001140361-25-006525.)
Portfolio and segment reporting
March 12, 2025, Acquisition of the AspenTech minority closed. Emerson completed the acquisition of Aspen Technology, Inc., buying in the outstanding shares it did not already own at $265 per share in cash following a tender offer that expired March 11, 2025 with approximately 72% of the unaffiliated shares tendered. Emersub CXV, Inc. merged into AspenTech under Section 251(h) of the Delaware General Corporation Law, with AspenTech surviving. The cost was approximately $7.2 billion; because Emerson already controlled AspenTech, the purchase is reported as an adjustment to equity rather than as a business combination. The expiration date had been extended by one day under a March 7, 2025 letter agreement. (Accessions 0001140361-25-008247, 0001140361-25-007760 and, for the accounting treatment, the Form 10-Q at accession 0000032604-26-000043.)
No further acquisitions or divestitures have been disclosed since. The only other transaction noted in the current filings is AspenTech's November 15, 2024 purchase of Open Grid Systems Limited for $46 million net of cash acquired, and there were no purchases of businesses in the nine months ended June 30, 2026.
November 20, 2025, Reportable segments restructured into five segments. Emerson announced that, with its transformation complete, it had revised its management organization and would report five segments beginning in fiscal 2026: Control Systems & Software and Test & Measurement (together the Software & Systems group), Sensors (formerly described as Measurement & Analytical) and Final Control (together the Intelligent Devices group), and Safety & Productivity. The former Discrete Automation segment was dismantled, with programmable automation controllers moving to Control Systems & Software, fluid and motion control to Final Control, and electrical equipment and materials joining to Safety & Productivity. Five fiscal years of recast segment history were furnished alongside. (Accession 0000032604-25-000094.)
Regulatory and legal
Tariff refunds under the IEEPA ruling. In February 2026 the U.S. Supreme Court ruled that the International Emergency Economic Powers Act does not authorize the imposition of tariffs. U.S. Customs and Border Protection opened a refund claims portal on April 20, 2026, and in the quarter ended June 30, 2026 Emerson filed claims and received $82 million of tariff refunds ($0.11 per share), recorded in cost of sales. This was a significant contributor to the quarter's gross margin, which rose 1.9 percentage points to 54.5%. The company states that the timing and amount of any further refunds remain uncertain and that no benefit has been recognized for additional potential refunds of IEEPA tariffs previously paid. The refund is excluded from adjusted earnings. (Form 10-Q, accession 0000032604-26-000043; the $82 million and $0.11 per share amounts also appear in the earnings release at accession 0000032604-26-000042.)
Governance and management
May 5, 2026, Jennifer G. Newstead elected to the Board. The Board elected Newstead, Senior Vice President and General Counsel of Apple and previously Chief Legal Officer of Meta, as a director effective August 3, 2026, serving on the Compensation Committee and the Corporate Governance and Nominating Committee. The Board expands to 11 members. She received a $95,000 pro rata restricted stock unit award against the $190,000 RSU portion of the annual non-management director retainer. (Accession 0000032604-26-000034.)
February 3, 2026, Annual meeting; board declassification proposal failed. Shareholders elected the three nominated directors, approved executive compensation on an advisory basis and ratified KPMG LLP as auditor for fiscal 2026. A proposal to amend the Restated Articles of Incorporation to declassify the Board failed: it required 85% of outstanding shares in favor, and while 415,208,804 shares voted for against only 5,746,906 opposed, that fell short of the supermajority threshold. (Accession 0000032604-26-000017.)
November 13, 2025, Special premium-priced option awards to the CEO and COO. The Compensation Committee granted President and CEO Lal Karsanbhai and EVP and COO Ram Krishnan 350,000 stock options each, in five equal tranches of 70,000 with exercise prices of $128.46 (the grant-date closing price) and at 25%, 50%, 75% and 100% premiums to it, $160.575, $192.69, $224.805 and $256.92. Each tranche vests pro rata over five years and must be exercised within ten years. Eighty percent of the awards are struck above the market price at grant, so they deliver value only on substantial share price appreciation. (Accession 0000032604-25-000091.)
March 10, 2025, Director resignation. The Board accepted the resignation of Leticia Gonçalves Lourenco, effective immediately, following a change in her principal occupation. (Accession 0000950103-25-003340.)
Not reflected in the filings
No current report discloses a pending or signed acquisition, divestiture, impairment, restructuring program announcement, or material litigation outcome beyond the tariff refunds described above. Emerson's restructuring spending is disclosed through the periodic reports rather than as a discrete announced program. Restructuring and related costs were $99 million in the third quarter of fiscal 2026 against $41 million a year earlier: $87 million and $37 million of that sits in other deductions, net, with the remaining $12 million and $4 million reported in cost of sales and selling, general and administrative expenses.
Financials
Figures link to the filing they came from. Wherever the SEC filing tags a number, that number is linked: click it and the filing opens at the exact line that prints it. A figure with no link was either derived by AI, such as a margin, free cash flow or a trailing-twelve-month total, or taken from a filing that does not tag its numbers, such as an earnings release.
About this file
| Ticker | EMR |
|---|---|
| CIK | 0000032604 |
| Company | Emerson Electric Co. |
| Business type | industrial |
| Schema template | standard industrial (net sales, cost of sales, gross profit, pretax earnings, net earnings, diluted EPS; cash, total debt, total assets, total equity; operating cash flow, capex, free cash flow, dividends) |
| Reporting currency | USD |
| Converted to USD | no |
| Units | actual dollars (not millions); share counts are actual shares; per-share amounts are actual dollars per share |
EMR annual income statement, balance sheet and cash flow
Taken from the SEC filings and normalized to actual dollars.
| FY2023 | FY2024 | FY2025 | |
|---|---|---|---|
| Period start | 2022-10-01 | 2023-10-01 | 2024-10-01 |
| Period end | 2023-09-30 | 2024-09-30 | 2025-09-30 |
| Period type | fiscal year | fiscal year | fiscal year |
| Source accession | 10-K | 10-K | 10-K |
| Income statement | |||
| Net sales | 15,165,000,000 | 17,492,000,000 | 18,016,000,000 |
| Cost of sales | 7,738,000,000 | 8,607,000,000 | 8,497,000,000 |
| Selling general and administrative expenses | 4,186,000,000 | 5,142,000,000 | 5,103,000,000 |
| Gain on subordinated interest | -161,000,000 | -79,000,000 | 0 |
| Loss on copeland note receivable | 0 | 279,000,000 | 0 |
| Other deductions net | 506,000,000 | 1,434,000,000 | 1,245,000,000 |
| Interest expense net | 34,000,000 | 175,000,000 | 237,000,000 |
| Interest income from related party | -41,000,000 | -86,000,000 | 0 |
| Pretax earnings from continuing operations | 2,903,000,000 | 2,020,000,000 | 2,934,000,000 |
| Income taxes | 642,000,000 | 415,000,000 | 696,000,000 |
| Earnings from continuing operations | 2,261,000,000 | 1,605,000,000 | 2,238,000,000 |
| Discontinued operations net of tax | 10,939,000,000 | 350,000,000 | 8,000,000 |
| Net earnings | 13,200,000,000 | 1,955,000,000 | 2,246,000,000 |
| Less noncontrolling interests in earnings of subsidiaries | -19,000,000 | -13,000,000 | -47,000,000 |
| Net income attributable to common stockholders | 13,219,000,000 | 1,968,000,000 | 2,293,000,000 |
| Gross profit | 7,427,000,000 | 8,885,000,000 | 9,519,000,000 |
| Basic EPS | 23.00 | 3.44 | 4.06 |
| Diluted EPS | 22.88 | 3.43 | 4.04 |
| Diluted EPS continuing operations | 3.96 | 2.82 | 4.03 |
| Basic EPS continuing operations | 3.98 | 2.83 | 4.05 |
| Basic shares | 574,200,000 | 571,300,000 | 564,000,000 |
| Diluted shares | 577,300,000 | 574,000,000 | 566,700,000 |
| Cash flow | |||
| Net earnings | 13,200,000,000 | 1,955,000,000 | 2,246,000,000 |
| Depreciation and amortization | 1,051,000,000 | 1,689,000,000 | 1,518,000,000 |
| Cash from continuing operations | 2,710,000,000 | 3,317,000,000 | 3,676,000,000 |
| Cash from discontinued operations | -2,073,000,000 | 15,000,000 | -578,000,000 |
| Operating cash flow | 637,000,000 | 3,332,000,000 | 3,098,000,000 |
| Capex | -363,000,000 | -419,000,000 | -431,000,000 |
| Purchases of businesses net of cash acquired | -705,000,000 | -8,342,000,000 | -37,000,000 |
| Cash provided by used in investing activities | 12,415,000,000 | -5,360,000,000 | -593,000,000 |
| Dividends paid | -1,198,000,000 | -1,201,000,000 | -1,192,000,000 |
| Purchases of common stock | -2,000,000,000 | -435,000,000 | -1,167,000,000 |
| Cash used in financing activities | -6,823,000,000 | -2,455,000,000 | -4,510,000,000 |
| Increase decrease in cash and equivalents | 6,247,000,000 | -4,463,000,000 | -2,044,000,000 |
| Ending cash and equivalents | 8,051,000,000 | 3,588,000,000 | 1,544,000,000 |
| Free cash flow | 274,000,000 | 2,913,000,000 | 2,667,000,000 |
| Balance sheet | |||
| Cash and equivalents | 3,588,000,000 | 1,544,000,000 | |
| Receivables net | 2,927,000,000 | 3,101,000,000 | |
| Inventories | 2,180,000,000 | 2,213,000,000 | |
| Other current assets | 1,497,000,000 | 1,725,000,000 | |
| Total current assets | 10,192,000,000 | 8,583,000,000 | |
| Property plant and equipment net | 2,807,000,000 | 2,871,000,000 | |
| Goodwill | 18,067,000,000 | 18,193,000,000 | |
| Other intangible assets | 10,436,000,000 | 9,458,000,000 | |
| Other assets | 2,744,000,000 | 2,859,000,000 | |
| Total other assets | 31,247,000,000 | 30,510,000,000 | |
| Total assets | 44,246,000,000 | 41,964,000,000 | |
| Short term borrowings and current maturities of long term debt | 532,000,000 | 4,797,000,000 | |
| Accounts payable | 1,335,000,000 | 1,384,000,000 | |
| Accrued expenses | 3,875,000,000 | 3,616,000,000 | |
| Total current liabilities | 5,742,000,000 | 9,797,000,000 | |
| Long term debt | 7,155,000,000 | 8,319,000,000 | |
| Other liabilities | 3,840,000,000 | 3,550,000,000 | |
| Common stockholders equity | 21,636,000,000 | 20,282,000,000 | |
| Noncontrolling interests in subsidiaries | 5,873,000,000 | 16,000,000 | |
| Total equity | 27,509,000,000 | 20,298,000,000 | |
| Total liabilities | 16,737,000,000 | 21,666,000,000 | |
| Total debt | 7,687,000,000 | 13,116,000,000 | |
| Shares outstanding | 570,200,000 | 562,800,000 | |
EMR quarterly income statement, balance sheet and cash flow
Taken from the SEC filings and normalized to actual dollars.
| Q3 FY2025 | Q3 FY2026 | |
|---|---|---|
| Period start | 2025-04-01 | 2026-04-01 |
| Period end | 2025-06-30 | 2026-06-30 |
| Period type | three months | three months |
| Source accession | 10-Q | 10-Q |
| Cash flow source accession | 0000032604-26-000042 | 0000032604-26-000042 |
| Income statement | ||
| Net sales | 4,553,000,000 | 4,873,000,000 |
| Cost of sales | 2,160,000,000 | 2,218,000,000 |
| Selling general and administrative expenses | 1,266,000,000 | 1,343,000,000 |
| Other deductions net | 298,000,000 | 311,000,000 |
| Interest expense net | 95,000,000 | 85,000,000 |
| Pretax earnings from continuing operations | 734,000,000 | 916,000,000 |
| Income taxes | 154,000,000 | 198,000,000 |
| Earnings from continuing operations | 580,000,000 | 718,000,000 |
| Discontinued operations net of tax | 6,000,000 | 0 |
| Net earnings | 586,000,000 | 718,000,000 |
| Less noncontrolling interests in earnings of subsidiaries | 0 | 0 |
| Net income attributable to common stockholders | 586,000,000 | 718,000,000 |
| Gross profit | 2,393,000,000 | 2,655,000,000 |
| Basic EPS continuing operations | 1.03 | 1.28 |
| Basic EPS | 1.04 | 1.28 |
| Diluted EPS continuing operations | 1.03 | 1.28 |
| Diluted EPS | 1.04 | 1.28 |
| Basic shares | 562,100,000 | 558,800,000 |
| Diluted shares | 564,700,000 | 561,100,000 |
| Cash flow | ||
| Operating cash flow | 1,062,000,000 | 1,425,000,000 |
| Capex | -92,000,000 | -102,000,000 |
| Free cash flow | 970,000,000 | 1,323,000,000 |
| Depreciation and amortization | 372,000,000 | 377,000,000 |
| Segment results | ||
| Control systems and software | ||
| Net sales | 1,120,000,000 | 1,199,000,000 |
| Segment earnings | 271,000,000 | 285,000,000 |
| Test and measurement | ||
| Net sales | 360,000,000 | 445,000,000 |
| Segment earnings | -26,000,000 | 11,000,000 |
| Software and systems group | ||
| Net sales | 1,480,000,000 | 1,644,000,000 |
| Segment earnings | 245,000,000 | 296,000,000 |
| Sensors | ||
| Net sales | 1,013,000,000 | 1,091,000,000 |
| Segment earnings | 246,000,000 | 303,000,000 |
| Final control | ||
| Net sales | 1,522,000,000 | 1,586,000,000 |
| Segment earnings | 351,000,000 | 349,000,000 |
| Intelligent devices group | ||
| Net sales | 2,535,000,000 | 2,677,000,000 |
| Segment earnings | 597,000,000 | 652,000,000 |
| Safety and productivity | ||
| Net sales | 538,000,000 | 552,000,000 |
| Segment earnings | 103,000,000 | 93,000,000 |
| Balance sheet | ||
| Cash and equivalents | 2,180,000,000 | |
| Receivables net | 3,057,000,000 | |
| Inventories | 2,513,000,000 | |
| Other current assets | 1,905,000,000 | |
| Total current assets | 9,655,000,000 | |
| Property plant and equipment net | 2,861,000,000 | |
| Goodwill | 18,122,000,000 | |
| Other intangible assets | 8,686,000,000 | |
| Other assets | 2,884,000,000 | |
| Total other assets | 29,692,000,000 | |
| Total assets | 42,208,000,000 | |
| Short term borrowings and current maturities of long term debt | 5,587,000,000 | |
| Accounts payable | 1,613,000,000 | |
| Accrued expenses | 3,572,000,000 | |
| Total current liabilities | 10,772,000,000 | |
| Long term debt | 7,526,000,000 | |
| Other liabilities | 3,516,000,000 | |
| Common stockholders equity | 20,379,000,000 | |
| Noncontrolling interests in subsidiaries | 15,000,000 | |
| Total equity | 20,394,000,000 | |
| Total liabilities | 21,814,000,000 | |
| Total debt | 13,113,000,000 | |
| Shares outstanding | 557,800,000 | |
EMR year-to-date income statement and cash flow
Taken from the SEC filings and normalized to actual dollars.
| Nine months ended June 30, 2026 | Nine months ended June 30, 2025 | |
|---|---|---|
| Period start | 2025-10-01 | 2024-10-01 |
| Period end | 2026-06-30 | 2025-06-30 |
| Period type | nine months | nine months |
| Source accession | 10-Q | 10-Q |
| Income statement | ||
| Net sales | 13,781,000,000 | 13,161,000,000 |
| Cost of sales | 6,393,000,000 | 6,161,000,000 |
| Selling general and administrative expenses | 3,902,000,000 | 3,773,000,000 |
| Other deductions net | 744,000,000 | 944,000,000 |
| Interest expense net | 258,000,000 | 145,000,000 |
| Pretax earnings from continuing operations | 2,484,000,000 | 2,138,000,000 |
| Income taxes | 542,000,000 | 536,000,000 |
| Earnings from continuing operations | 1,942,000,000 | 1,602,000,000 |
| Discontinued operations net of tax | 0 | 7,000,000 |
| Net earnings | 1,942,000,000 | 1,609,000,000 |
| Less noncontrolling interests in earnings of subsidiaries | 1,000,000 | -48,000,000 |
| Net income attributable to common stockholders | 1,941,000,000 | 1,657,000,000 |
| Gross profit | 7,388,000,000 | 7,000,000,000 |
| Basic EPS continuing operations | 3.46 | 2.92 |
| Basic EPS | 3.46 | 2.93 |
| Diluted EPS continuing operations | 3.45 | 2.91 |
| Diluted EPS | 3.45 | 2.92 |
| Basic shares | 560,400,000 | 564,500,000 |
| Diluted shares | 562,700,000 | 567,100,000 |
| Cash flow | ||
| Net earnings | 1,942,000,000 | 1,609,000,000 |
| Depreciation and amortization | 1,105,000,000 | 1,139,000,000 |
| Cash from continuing operations | 2,902,000,000 | 2,664,000,000 |
| Cash from discontinued operations | 0 | -576,000,000 |
| Operating cash flow | 2,902,000,000 | 2,088,000,000 |
| Capex | -284,000,000 | -263,000,000 |
| Purchases of businesses net of cash acquired | 0 | -36,000,000 |
| Cash provided by used in investing activities | -322,000,000 | -393,000,000 |
| Dividends paid | -935,000,000 | -895,000,000 |
| Purchases of common stock | -898,000,000 | -1,147,000,000 |
| Cash used in financing activities | -1,920,000,000 | -3,019,000,000 |
| Increase decrease in cash and equivalents | 636,000,000 | -1,369,000,000 |
| Ending cash and equivalents | 2,180,000,000 | 2,219,000,000 |
| Free cash flow | 2,618,000,000 | 1,825,000,000 |
| Segment results | ||
| Control systems and software | ||
| Net sales | 3,332,000,000 | 3,235,000,000 |
| Segment earnings | 741,000,000 | 717,000,000 |
| Test and measurement | ||
| Net sales | 1,268,000,000 | 1,077,000,000 |
| Segment earnings | 21,000,000 | -64,000,000 |
| Software and systems group | ||
| Net sales | 4,600,000,000 | 4,312,000,000 |
| Segment earnings | 762,000,000 | 653,000,000 |
| Sensors | ||
| Net sales | 3,111,000,000 | 2,986,000,000 |
| Segment earnings | 845,000,000 | 795,000,000 |
| Final control | ||
| Net sales | 4,469,000,000 | 4,315,000,000 |
| Segment earnings | 1,033,000,000 | 1,012,000,000 |
| Intelligent devices group | ||
| Net sales | 7,580,000,000 | 7,301,000,000 |
| Segment earnings | 1,878,000,000 | 1,807,000,000 |
| Safety and productivity | ||
| Net sales | 1,601,000,000 | 1,548,000,000 |
| Segment earnings | 298,000,000 | 305,000,000 |
EMR trailing twelve month income statement and cash flow
Derived by AI from the figures the filings report. No filing prints these, so none of them is linked.
| Twelve months ended June 30, 2026 | |
|---|---|
| Period start | 2025-07-01 |
| Period end | 2026-06-30 |
| Period type | trailing twelve months |
| Source accessions | 10-K, 10-Q |
| Income statement | |
| Net sales | 18,636,000,000 |
| Cost of sales | 8,729,000,000 |
| Selling general and administrative expenses | 5,232,000,000 |
| Other deductions net | 1,045,000,000 |
| Interest expense net | 350,000,000 |
| Pretax earnings from continuing operations | 3,280,000,000 |
| Income taxes | 702,000,000 |
| Earnings from continuing operations | 2,578,000,000 |
| Discontinued operations net of tax | 1,000,000 |
| Net earnings | 2,579,000,000 |
| Less noncontrolling interests in earnings of subsidiaries | 2,000,000 |
| Net income attributable to common stockholders | 2,577,000,000 |
| Basic shares | 559,900,000 |
| Diluted shares | 562,300,000 |
| Basic EPS | 4.59 |
| Diluted EPS | 4.57 |
| Basic EPS continuing operations | 4.59 |
| Diluted EPS continuing operations | 4.57 |
| Gross profit | 9,907,000,000 |
| Cash flow | |
| Operating cash flow | 3,912,000,000 |
| Capex | -452,000,000 |
| Dividends paid | -1,232,000,000 |
| Depreciation and amortization | 1,484,000,000 |
| Free cash flow | 3,460,000,000 |
- Derivation. fiscal 2025 plus the nine months ended June 30, 2026 less the nine months ended June 30, 2025
Adjustments
| Splits applied | none |
|---|---|
| ADR ratio | n/a |
| FX | None. Emerson reports in U.S. dollars, so no currency translation was applied. |
| Note | Emerson has had no stock split in the period covered by these filings and is not an ADR, so no per-share adjustment was needed. |
Source filings
| Role | Current | Form | Fiscal year | Fiscal period | Tag | Period end | Filed | Accession | Source |
|---|---|---|---|---|---|---|---|---|---|
| annual | no | 10-K | 2025 | FY | FY25 | 2025-09-30 | 2025-11-10 | 0000032604-25-000087 | reported |
| quarterly | yes | 10-Q | 2026 | Q3 | FY26Q3 | 2026-06-30 | 2026-08-04 | 0000032604-26-000043 | facts |
Notes
- Schema: Emerson is a diversified industrial automation manufacturer, so the standard industrial template is used - net sales, cost of sales, gross profit, pretax earnings, net earnings and diluted EPS; cash, total debt, total assets and total equity; operating cash flow, capital expenditures, free cash flow and dividends.
- Coverage: the periods shown here are those the FY2025 10-K and the Q3 FY2026 10-Q put on the face of their statements. The FY2025 10-K (accession 0000032604-25-000087) presents three years of earnings and cash flows (fiscal 2023, 2024 and 2025) and two years of balance sheet (September 30, 2024 and 2025). The Q3 FY2026 10-Q (accession 0000032604-26-000043) presents the three months and the nine months ended June 30, 2026 and June 30, 2025, and balance sheets at September 30, 2025 and June 30, 2026. Fiscal 2023 therefore carries no balance sheet, because the 10-K does not print one for that date.
- Emerson's fiscal year ends September 30. Fiscal 2026 runs from October 1, 2025 to September 30, 2026, so the quarter ended June 30, 2026 is the third quarter of fiscal 2026.
- Emerson's income statement does not print a gross profit line or an operating income line. Gross profit here is net sales less cost of sales, computed for every period on the same basis. The profit subtotal Emerson itself reports is pretax earnings from continuing operations, which is carried in every period. Note that Emerson's cost of sales includes intangibles amortization (49 million dollars in the third quarter of fiscal 2026 and 50 million in the year-ago quarter) and part of its restructuring charge, so this gross margin is not on the same basis as a company that reports those below the line.
- The 10-Q's consolidated statement of cash flows covers the nine months only - it prints no three-month column. The operating cash flow, capital expenditures and free cash flow shown for the third quarter of fiscal 2026 and the third quarter of fiscal 2025 therefore come from the free cash flow reconciliation in Emerson's third-quarter fiscal 2026 earnings release, furnished as exhibit 99.1 to the 8-K of August 4, 2026 (accession 0000032604-26-000042). Those are press-release figures, not 10-Q figures. Every other cash flow figure shown here is taken from the cash flow statement in the 10-K or the 10-Q. Free cash flow is operating cash flow less capital expenditures throughout, which is Emerson's own definition.
- Quarterly depreciation and amortization is taken from the total row of the 10-Q's segment note, which presents it for the three months as well as the nine months; the cash flow statement gives only the nine-month figure.
- Emerson's balance sheet does not print a total liabilities subtotal. Total liabilities here is total current liabilities plus long-term debt plus other liabilities, which ties to total assets less total equity in every period. Total debt is short-term borrowings and current maturities of long-term debt plus long-term debt. Shares outstanding is read from the balance-sheet caption (and, for June 30, 2026, from the 10-Q cover page): 570.2 million at September 30, 2024, 562.8 million at September 30, 2025 and 557.8 million at June 30, 2026.
- Fiscal 2023 is dominated by discontinued operations. Of the 13,219 million dollars of net earnings to common stockholders that year, 10,933 million came from discontinued operations - the Climate Technologies (Copeland) divestiture - against 2,286 million from continuing operations. Fiscal 2023 diluted EPS of 22.88 dollars is therefore not comparable to later years; continuing-operations diluted EPS that year was 3.96 dollars. The same distortion runs through fiscal 2023 cash flow: operating cash flow of 637 million is continuing-operations cash of 2,710 million less a 2,073 million outflow from discontinued operations, largely the tax on that gain, so fiscal 2023 free cash flow of 274 million is not a normal year.
- On March 12, 2025 Emerson bought in the remaining Aspen Technology shares it did not already own, paying 7,244 million dollars. That is why noncontrolling interests in the balance sheet fall from 5,873 million at September 30, 2024 to 16 million at September 30, 2025, why total equity falls even though the company was profitable, and why total debt rises from 7,687 million to 13,116 million over fiscal 2025. AspenTech is now a wholly owned subsidiary and its results are reported inside Control Systems & Software for all periods presented in the 10-K.
- Segments: effective fiscal 2026 Emerson reports five segments - Control Systems & Software and Test & Measurement (reported together as the Software & Systems group), Sensors and Final Control (reported together as the Intelligent Devices group), and Safety & Productivity. The 10-Q reclassifies the prior-year quarter and nine months onto that basis, so the segment figures carried for the quarters and the year-to-date blocks are comparable with each other. No segment breakdown is carried on the annual periods: the FY2025 10-K predates the change and presents fiscal 2023 to 2025 on the earlier segment structure, which would not line up with the quarterly split. Segment earnings are earnings before interest and taxes as Emerson defines them, and do not sum to pretax earnings - corporate items, stock compensation, unallocated pension and net interest expense sit outside the segments.
- The third quarter of fiscal 2026 includes an 82 million dollar benefit from refunds of tariffs collected under the International Emergency Economic Powers Act, recorded in cost of sales and worth 0.11 dollars per share. Emerson says the timing and amount of any further refunds remain uncertain and that no benefit has been recognized for additional potential refunds.
- The trailing-twelve-month block is derived, not filed: fiscal 2025 plus the nine months ended June 30, 2026 less the nine months ended June 30, 2025. Trailing per-share and weighted-share figures are derived the same way and are approximations - a weighted average share count is not additive across periods - so the trailing diluted EPS of 4.57 dollars sits slightly below trailing net earnings to common divided by the trailing share count. No trailing balance sheet is given, because a balance sheet is a point in time and the June 30, 2026 balance sheet is already carried on the quarter.
- The year-to-date block is the nine months ended June 30, 2026 as the 10-Q presents it, with the nine months ended June 30, 2025 held inside it as the prior-year comparative.
- No split, currency or depositary-receipt adjustment applies. Emerson reports in U.S. dollars, has had no stock split over the period these filings cover, and its common stock is an ordinary U.S. listing rather than a depositary receipt, so per-share figures are carried exactly as the filings print them.
Uncertainties
- The three-month operating cash flow, capital expenditures and free cash flow for the third quarter of fiscal 2026 and the third quarter of fiscal 2025 are not presented in the 10-Q at all. They are taken from the earnings release furnished with the 8-K of August 4, 2026 (accession 0000032604-26-000042), which is furnished rather than filed. They cannot be cross-checked against the 10-Q, because the 10-Q gives only nine-month cash flows.
- Trailing-twelve-month figures are derived by arithmetic rather than reported by Emerson. The per-share and weighted-share amounts in that block are the least exact of them, because share counts are weighted averages and do not add across periods.
- Gross profit and gross margin are derived; Emerson publishes neither, and its cost of sales carries intangibles amortization and some restructuring cost, so these margins are not comparable line-for-line with companies that present those items separately.
- Total liabilities is a sum of the three liability subtotals Emerson prints rather than a figure it reports. It ties to total assets less total equity in every period carried here.
- Shares outstanding is read from the narrative caption of the balance sheet (and the 10-Q cover page) rather than from a numeric column of the statement.
- Fiscal 2023 carries no balance sheet, and the annual periods carry no segment breakdown. Neither is a gap in the record - the FY2025 10-K simply does not print them on the basis used here.
- Emerson's fiscal 2026 outlook figures quoted in the 10-K and in the earnings releases are management guidance and are deliberately not carried here; only reported results are shown.
Company details
| Name | Emerson Electric Co |
|---|---|
| Ticker | EMR |
| CIK | 0000032604 |
| Exchange | NYSE |
| State | Missouri |
| Incorporation | Missouri |
| SIC | 3600 |
| Office | Manufacturing |
| Industry | Electronic & Other Electrical Equipment (No Computer Equip) |
Fiscal period
| Fiscal year | 2026 |
|---|---|
| Fiscal period | Q3 |
| Tag | FY26Q3 |
| Period end | 2026-06-30 |
| Form | 10-Q |
| Accession | 0000032604-26-000043 |
| Fiscal year end | 0930 |
| Source | facts |